Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Biomedicine Archives - Page 2 of 3 - Neuro-Psychology
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory
Home
Genentech: Baris Bingol | Principal Scientist, Neuroscience
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Vaccines | Free Full-Text | SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books - Amazon.com
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
Prof. Ioannis P. TROUGAKOS – Mu.Ta.Lig – COST ACTION CA15135
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Natural compounds with anti-ageing activity - Natural Product Reports (RSC Publishing) DOI:10.1039/C3NP70031C
How to pronounce Ioannis P Trougakos | HowToPronounce.com
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Loop | Ioannis Trougakos
Olive Bioactives: applications and prospects | LE STUDIUM
